Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Termination

VENUESCREEN

via BROWNSTEIN HYATT FARBER SCHRECK, LLP

4th Quarter (Oct 1 - Dec 31) · 2020Posted Apr 20, 2021Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: VENUESCREEN
Description: Non-contact health screenings
Location: Minnesota · United States of America

Registrant

Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to COVID-19 screening
LobbyistsMARC LAMPKIN · GRETA JOYNES · WILLIAM MCGRATH

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

VENUESCREEN — Lobbying — Receipts Report